Improving clinical trial enrollment in minority racial and ethnic patients with gynecologic malignancy
Purpose: Racial and ethnic minorities remain underrepresented in clinical trials . Underrepresentation of racial groups leads to the selection of therapeutic interventions that may not be representative of the population expected to use the medicine. This study evaluates the effectiveness of a set o...
Saved in:
Main Authors: | Olivia D. Lara (Author), Kathryn Allen (Author), Amin Yakubov (Author), Bhavana Pothuri (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The diabetes cardiovascular outcomes trials and racial and ethnic minority enrollment: impact, barriers, and potential solutions
by: Matthew R. Sinclair, et al.
Published: (2024) -
Improving the enrollment of women and racially/ethnically diverse populations in cardiovascular clinical trials: An ASPC practice statement
by: Erin D. Michos, et al.
Published: (2021) -
The Impact of an Educational Video on Clinical Trial Enrollment and Knowledge in Ethnic Minorities: A Randomized Control Trial
by: Jeannine S. Skinner, et al.
Published: (2019) -
Representation of ethnic and racial minority groups in European vaccine trials: a quantitative analysis of clinical trials registries
by: Natasha F Puttick, et al.
Published: (2023) -
Medical marijuana utilization in gynecologic cancer patients
by: Julia Fehniger, et al.
Published: (2021)